Skip to main content
Porto

Main navigation

  • Home
  • PMMNG Meetings
    • PMMNG Monthly Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma 5K
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

high-risk disease

MMRF logoWhat:  Webcast
When: Saturday, February 27, 2021 10:00 AM–12:00 PM (ET)
Where: Web

Tags
event
archived
webcast
mmrf
research
treatment
triple-class refractory disease
high-risk disease
Dr. Saad Z. Usmani
Dr. Melissa Alsina
  • Read more about MMRF: Expert Session

Myeloma Crowd logoWhat: Webcast
When: Tuesday March 15, 2022 7:00-8:15 PM ET
Where: Web
More Information & Register

Tags
event
webcast
upcoming
myeloma crowd
treatment
daratumumab
darzalex
relapsed/refractory
high-risk disease
q&a
Audrey Burton-Bethke
Dr. Luciano Costa
  • Read more about Myeloma Crowd: Using Daratumumab to Treat High-Risk Myeloma Patients
Subscribe to high-risk disease